Nita M. Minnifield

Array ( [id] => 10398213 [patent_doc_number] => 20150283221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'ATTENUATED LISTERIA MONOCYTOGENES MUTANT AS A VACCINE VECTOR FOR THE DELIVERY OF EXOGENEOUS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 14/680397 [patent_app_country] => US [patent_app_date] => 2015-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12416 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11588503 [patent_doc_number] => 20170112914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 15/300852 [patent_app_country] => US [patent_app_date] => 2015-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11746 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706827 [patent_doc_number] => 20160052974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/673480 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22734 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311657 [patent_doc_number] => 20150196659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'BIFUNCTIONAL PROTEIN ANCHORS' [patent_app_type] => utility [patent_app_number] => 14/667455 [patent_app_country] => US [patent_app_date] => 2015-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11698 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14667455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10339284 [patent_doc_number] => 20150224289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'Treatment of Renal Hypertension or Carotid Sinus Syndrome with Adventitial Pharmaceutical Sympathetic Denervation or Neuromodulation' [patent_app_type] => utility [patent_app_number] => 14/661320 [patent_app_country] => US [patent_app_date] => 2015-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15598 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11225355 [patent_doc_number] => 09453068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Antibodies that neutralize botulinum neurotoxins' [patent_app_type] => utility [patent_app_number] => 14/634355 [patent_app_country] => US [patent_app_date] => 2015-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 46551 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12562773 [patent_doc_number] => 10016493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Compositions and methods of enhancing immune responses to Eimeria [patent_app_type] => utility [patent_app_number] => 14/623050 [patent_app_country] => US [patent_app_date] => 2015-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6591 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14623050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13137493 [patent_doc_number] => 10086058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-02 [patent_title] => AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplasma phagocytophilum infection [patent_app_type] => utility [patent_app_number] => 15/115954 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 71 [patent_no_of_words] => 30650 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11127972 [patent_doc_number] => 20160324948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Streptococcus pneumoniae capsular polysaccharides and conjugates thereof' [patent_app_type] => utility [patent_app_number] => 15/110634 [patent_app_country] => US [patent_app_date] => 2015-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22120 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11381639 [patent_doc_number] => 20170007695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'PEPTIDE/Beta-1,3-GLUCAN COMPLEX AND PRODUCTION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE/Beta-1,3-GLUCAN COMPLEX' [patent_app_type] => utility [patent_app_number] => 15/116306 [patent_app_country] => US [patent_app_date] => 2014-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11770 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10388040 [patent_doc_number] => 20150273047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 14/579353 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19653 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10458000 [patent_doc_number] => 20150343015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'ANTIMICROBIAL AND ANTI-INFLAMMATORY PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/573120 [patent_app_country] => US [patent_app_date] => 2014-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21240 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14573120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11116373 [patent_doc_number] => 20160313346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'INTERFERON-GAMMA RELEASE ASSAYS FOR DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 15/105179 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9400 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10280006 [patent_doc_number] => 20150165003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/567289 [patent_app_country] => US [patent_app_date] => 2014-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15539 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14567289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17569946 [patent_doc_number] => 11318200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => Methods and compositions for induction of immune response [patent_app_type] => utility [patent_app_number] => 15/039733 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5573 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13196471 [patent_doc_number] => 10113145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-30 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 15/109133 [patent_app_country] => US [patent_app_date] => 2014-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 12307 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11099624 [patent_doc_number] => 20160296595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT' [patent_app_type] => utility [patent_app_number] => 15/036424 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14430 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10247285 [patent_doc_number] => 20150132282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN' [patent_app_type] => utility [patent_app_number] => 14/538503 [patent_app_country] => US [patent_app_date] => 2014-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10500 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14538503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13129165 [patent_doc_number] => 10082509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Method for labeling specifically living and bacteria comprising the use of modified monosaccharide compounds [patent_app_type] => utility [patent_app_number] => 15/028155 [patent_app_country] => US [patent_app_date] => 2014-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 11549 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209246 [patent_doc_number] => 20150094236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES' [patent_app_type] => utility [patent_app_number] => 14/524744 [patent_app_country] => US [patent_app_date] => 2014-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9439 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14524744 [rel_patent_id] =>[rel_patent_doc_number] =>)